It is believed that such destabilization of client proteins (like raf, Src, Lck, Wee1, Mek, Cdk4, Src, Ck2, Akt, ErbB2 etc.)is responsible for the anti-mitotic and anti-tumor activity of the drug. The gene discussed is CDK4; the disease is neoplasm.